Paraneoplastic Neurologic Disorders

Search Trials
Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis
Status:
Not yet recruiting
Last Changed:
Jun 9, 2017
First Changed:
Jun 9, 2017
Disease(s):
Anti-NMDAR Encephalitis
Intervention(s):
IA sessionRituximab
Clinical Trial of a Serious Game for Individuals With SCI/D
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Spinal Cord Injury
Intervention(s):
SCI Hard
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Status:
Unknown status
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Acute Disseminated Encephalomyelitis
Intervention(s):
Plasma exchange
Safety and Tolerability of Rituximab in Neuromyelitis Optica
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Neuromyelitis Optica
Intervention(s):
Rituximab
Biobank For MS And Other Demyelinating Diseases
Status:
Active, not recruiting
Last Changed:
Jan 1, 1970
First Changed:
Sep 3, 2007
Disease(s):
Multiple Sclerosis

Connect. Empower. Inspire.